LONDON (Reuters) - Generic competition to AstraZeneca's top-selling acid reflux drug Nexium moved a step closer in Canada, after a court rejected the drugmaker's bid to stop a copycat version from ...
CHICAGO -- U.S. employers, struggling to tame double-digit health inflation, are putting the squeeze on AstraZeneca's ulcer drug Nexium, a product the Anglo-Swedish drug maker sorely needs to boost ...
Will the FDA ever allow Ranbaxy Laboratories to sell a generic version of the Nexium heartburn pill? The Connecticut attorney general wants to know what is taking the agency so long, because Ranbaxy ...
TRENTON, N.J. (AP) -- Drugmakers AstraZeneca PLC and Pfizer Inc. have reached a deal giving Pfizer future rights to sell a nonprescription version of AstraZeneca's blockbuster heartburn drug, Nexium, ...
The FDA approved the first generic version of Nexium — esomeprazole magnesium delayed-release capsules — to treat gastroesophageal reflux disease. Esomeprazole is a proton pump inhibitor that reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback